Beyond the Headlines, Columns-Drugs & Supplements, January 2006
January 6, 2006
SEC Approves Proposed Merger Between J&J and Guidant NEW BRUNSWICK, N.J. - The Securities and Exchange Commission approved on Dec. 28 the revised merger agreement between Johnson & Johnson and Guidant Corp. The merger was approved by J&J's board of directors and Guidant shareholders will vote on Jan. 31. J&J announced on Nov. 15 that it will acquire the company for $21.5 billion, $4.4 billion less than J&J previously offered. J&J and Guidant originally entered into an agreement in December 2004, but the companies revised the agreement after J&J said that recent defibrillator and pacemaker …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation ConferenceApril 08, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's MDL Conference: Depo-Provera and Current MDL CasesJanuary 29, 2025 - Miami Beach, FL
The Coral Ballroom at the Fontainebleau Miami Beach
|